Purolite is investing in a new high value manufacturing facility at its European HQ in Llantrisant secured with support from the Welsh Labour Government.
This will create and safeguard 55 jobs and provide a £120m boost for Welsh suppliers over the next five years.
The new state of the art facility will produce agarose based resins based on technology developed at Llantrisant, which is Purolite’s European R&D centre Centre of Excellence. It will have an initial annual capacity of 100,000 litres.
Agarose resins are integral technology used by pharmaceutical developers in the manufacture of modern medicines targeting the treatment of cancer, rheumatoid arthritis and well know age related diseases.